Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Keke Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2795-6806; OpenAlex author ID A5044106802. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2023: 2 papers · 2024: 1 paper

Papers 3

  1. Retraction Note: Palmitoyl transferases act as novel drug targets for pancreatic cancer. Last author DOI 10.1186/s12967-024-05202-x↗
  2. Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. First author DOI 10.1016/j.biopha.2023.114567↗
  3. Palmitoyl transferases act as novel drug targets for pancreatic cancer. Last author DOI 10.1186/s12967-023-04098-3↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Liu · 3 shared papers, 2023–2024 · strength 0.73
  2. Zhiqing Lin · 3 shared papers, 2023–2024 · strength 0.73
  3. Hui Guo · 1 shared paper, 2023 · strength 0.15
  4. Peng Zhang · 1 shared paper, 2023 · strength 0.15
  5. Jianmin Wu · 1 shared paper, 2023 · strength 0.15
  6. Wei Mei Guo · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.